Sodium Valproate º¹¿ëÈÄ ¹ß»ýÇÑ Hyperammonemia 1·Ê
A Case with Hyperammonemia due to Sodium Valproate
¹Ú¹Î±Ô, ÀÌ´ëÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú¹Î±Ô ( Park Min-Kyu )
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
ÀÌ´ëÈñ ( Lee Dae-Hie )
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
KMID : 0877219970010010146
Abstract
A 35-year-old woman diagnosed as complex partial seizure tilth secondary generalization has been treated with sodium valproate for the last 2 years. Progressive impairment of consciousness to deep drowsy state without focal neurologlc signs hospitalized her and the following medical evaluation repealed hyperammonemia without hepatic cause. Hyperammonemia as well as her previously deteriorated consciousness was improved after the discontinuation of sodium valproate. Moreover her hepatic function, biliary system and urea cycle were perfectly normal. Therefore, we report a case of hyperammonemia which is due to 2-year-course of sodium valproate administration could be recovered with removal of the offending agent. This suggests that sodium valproate induced hyperammonemia and hepatic failure after sodium valproate treatment main haute 3 different biochemical basis.
Å°¿öµå
Àΰݺ¯È; º¹ÇպκР¹ßÀÛ; °Ô½¬À©µå ÁõÈıº
Complex partial seizure; Sodium valporate; Hyperammoninemia
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸